>Marché des équipements de décongélation pour thérapie cellulaire et génique au Moyen-Orient et en Afrique, par modalité (paillasse et portable), échantillon (thérapies cellulaires et thérapies géniques), type ( système de décongélation manuel et système de décongélation automatique), application (traitement en amont et traitement en aval), utilisateur final ( banques de sang et centres de transfusion, hôpitaux et laboratoires de diagnostic, laboratoires de recherche et instituts universitaires, industrie biotechnologique et pharmaceutique , banques de sang de cordon et de cellules souches, banques de gènes et autres), canal de distribution (appel d'offres direct, distributeur tiers et autres), pays (Afrique du Sud, Arabie saoudite, Émirats arabes unis, Égypte, Israël et reste du Moyen-Orient et de l'Afrique) Tendances de l'industrie et prévisions jusqu'en 2028.
Analyse et perspectives du marché : marché des équipements de décongélation pour thérapie cellulaire et génique au Moyen-Orient et en Afrique
Le marché des équipements de décongélation pour thérapie cellulaire et génique devrait connaître une croissance du marché au cours de la période de prévision de 2021 à 2028. Data Bridge Market Research analyse que le marché croît avec un TCAC de 10,8 % au cours de la période de prévision de 2021 à 2028 et devrait atteindre 58,83 millions USD d'ici 2028. La prévalence croissante des maladies chroniques exige des solutions et des services avancés d'équipement de décongélation pour thérapie cellulaire et génique, ce qui constitue un moteur de la croissance du marché des équipements de décongélation pour thérapie cellulaire et génique.
L'équipement de décongélation pour thérapie cellulaire et génique est devenu facile en raison des progrès technologiques, car de nombreux acteurs clés du marché développent et lancent de nouvelles solutions pour élargir leur marché. De plus, l'augmentation des dépenses de santé dans les pays développés et en développement a alimenté la croissance du marché des équipements de décongélation pour thérapie cellulaire et génique. Le marché des équipements de décongélation pour thérapie cellulaire et génique est en croissance en raison de l'incidence accrue des maladies chroniques et de l'augmentation des progrès technologiques.
La prévalence croissante des maladies chroniques agit comme un moteur pour le marché des équipements de décongélation pour thérapie cellulaire et génique. L'augmentation des coûts associés à l'ingénierie de la thérapie cellulaire et génique réduit la demande d'équipements de décongélation pour thérapie cellulaire et génique, ce qui freine la croissance du marché des équipements de décongélation pour thérapie cellulaire et génique. L'essor des nouvelles avancées technologiques constitue une opportunité pour le marché des équipements de décongélation pour thérapie cellulaire et génique. Cependant, le manque d'accessibilité dans les pays à revenu faible et intermédiaire constitue un défi pour la croissance du marché des équipements de décongélation pour thérapie cellulaire et génique.
Le rapport sur le marché des équipements de décongélation pour thérapie cellulaire et génique fournit des détails sur la part de marché, les nouveaux développements et l'analyse du pipeline de produits, l'impact des acteurs du marché national et localisé, analyse les opportunités en termes de poches de revenus émergentes, les changements dans la réglementation du marché, les approbations de produits, les décisions stratégiques, les lancements de produits, les expansions géographiques et les innovations technologiques sur le marché. Pour comprendre l'analyse et le scénario du marché des équipements de décongélation pour thérapie cellulaire et génique, contactez Data Bridge Market Research pour un briefing d'analyste, notre équipe vous aidera à créer une solution d'impact sur les revenus pour atteindre votre objectif souhaité.
Portée et taille du marché des équipements de décongélation pour thérapie cellulaire et génique
Le marché des équipements de décongélation pour thérapie cellulaire et génique est segmenté en fonction de la modalité, de l'échantillon, du type, de l'application, de l'utilisateur final et du canal de distribution. La croissance entre les segments vous aide à analyser les niches de croissance et les stratégies pour aborder le marché et déterminer vos principaux domaines d'application et la différence entre vos marchés cibles.
- Sur la base d'échantillons, le marché des équipements de décongélation pour thérapie cellulaire et génique est segmenté en thérapies cellulaires et thérapies géniques. En 2021, le segment de la thérapie cellulaire devrait dominer le marché des équipements de décongélation pour thérapie cellulaire et génique en raison de la prévalence et de l'incidence croissantes du cancer.
- Sur la base du type, le marché des équipements de décongélation pour thérapie cellulaire et génique est segmenté en système de décongélation manuel et système de décongélation automatique. En 2021, le segment des systèmes de décongélation automatique devrait dominer le marché des équipements de décongélation pour thérapie cellulaire et génique, car il améliore la reproductibilité et minimise les erreurs humaines.
- En fonction des applications, le marché des équipements de décongélation pour thérapie cellulaire et génique est segmenté en traitement en amont et en traitement en aval. En 2021, le segment du traitement en amont devrait dominer le marché des équipements de décongélation pour thérapie cellulaire et génique en raison des avancées technologiques croissantes dans les systèmes de décongélation.
- Sur la base de l'utilisateur final, le marché des équipements de décongélation pour thérapie cellulaire et génique est segmenté en banques de sang et centres de transfusion, hôpitaux et laboratoires de diagnostic, laboratoires de recherche et instituts universitaires, industrie biotechnologique et pharmaceutique, banques de sang de cordon et de cellules souches, banques de gènes et autres. En 2021, le segment des banques de sang devrait dominer le marché des équipements de décongélation pour thérapie cellulaire et génique en raison de l'augmentation du nombre de banques de sang et de prestataires de soins de santé avancés dans les pays à revenu faible et intermédiaire.
- Sur la base du canal de distribution, le marché des équipements de décongélation pour thérapie cellulaire et génique est segmenté en appels d'offres directs, distributeurs tiers et autres. En 2021, le segment des appels d'offres directs devrait dominer le marché des équipements de décongélation pour thérapie cellulaire et génique, car la majorité des prestataires de soins de santé achètent des équipements de décongélation pour thérapie cellulaire et génique directement par appel d'offres direct.
Analyse du marché des équipements de décongélation pour thérapie cellulaire et génique au niveau des pays
The cell and gene therapy thawing equipment market is segmented on the based on the modality, sample, type, application, end user, distribution channel.
The countries covered in the cell and gene therapy thawing equipment market report are South Africa, Saudi Arabia, U.A.E., Israel, Egypt and rest of Middle East and Africa.
South Africa is expected to dominate the market increasing prevalence of chronic diseases.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Growing Strategic Activities by Major Market Players to Enhance the Awareness for Cell and gene therapy thawing equipment, is Boosting the Market Growth of Cell and Gene Therapy Thawing Equipment Market
The cell and gene therapy thawing equipment market also provides you with detailed market analysis for every country growth in particular market. Additionally, it provides the detail information regarding the market players’ strategy and their geographical presence. The data is available for historic period 2010 to 2019.
Competitive Landscape and Cell and Gene Therapy Thawing Equipment Market Share Analysis
Cell and gene therapy thawing equipment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to cell and gene therapy thawing equipment market.
The major companies which are dealing in the cell and gene therapy thawing equipment are Pluristem Therapeutics Inc., Genesis BPS, Eppendorf AG, Cytiva (A subsidiary of Danaher Corporation), Glenmark Pharmaceutical Inc., USA (A subsidiary of Glenmark), EDGE pharma, Cook, SARSTEDT AG & Co. KG, Barkey, Boekel Scientific, LABCOLD, Sartorious AG and Helmer Scientific Inc. among others domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Many contract and agreement are also initiated by the companies’ worldwide which are also accelerating the cell and gene therapy thawing equipment market.
For instance,
- En novembre 2020, Eppendorg AG a lancé le SmartBlock pour la décongélation des cellules en Inde. Le Smart Block Cell Thawing est une base pour le traitement en aval. Il est simple et pratique pour les scientifiques pour une utilisation ultérieure dans chaque laboratoire de manipulation de cellules.
La collaboration, le lancement de produits, l'expansion commerciale, les récompenses et la reconnaissance, les coentreprises et d'autres stratégies des acteurs du marché renforcent l'empreinte de l'entreprise sur le marché des équipements de décongélation pour thérapie cellulaire et génique, ce qui offre également l'avantage de la croissance des bénéfices de l'organisation.
SKU-
Accédez en ligne au rapport sur le premier cloud mondial de veille économique
- Tableau de bord d'analyse de données interactif
- Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
- Accès d'analyste de recherche pour la personnalisation et les requêtes
- Analyse de la concurrence avec tableau de bord interactif
- Dernières actualités, mises à jour et analyse des tendances
- Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Table des matières
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 MARKET APPLICATION COVERAGE GRID
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 USAGE OF THAWING EQUIPMENT IN UPSTREAM AND DOWNSTREAM PROCESSES
5.1 UPSTREAM PROCESS
5.2 DOWNSTREAM PROCESS
6 CELL AND GENE THERAPY WORKFLOW USING THAWING EQUIPMENT
7 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: REGULATIONS
7.1 CANADA
7.2 THE U.S.
7.3 EUROPE
7.4 GENE THERAPY LEGISLATION IN AUSTRIA
7.5 GENE THERAPY LEGISLATION IN BULGARIA
7.6 JAPAN
7.7 ITALY
7.8 MALAYSIA
8 REGIONAL SUMMARY
9 MARKET OVERVIEW
9.1 DRIVERS
9.1.1 INCREASE IN CASES OF GENETIC DISEASES SUCH AS CYSTIC FIBROSIS AND SICKLE CELL ANEMIA
9.1.2 RISE IN INVESTMENT IN R&D FOR DEVELOPMENT OF CELL AND GENE THERAPIES
9.1.3 GOVERNMENT INITIATIVES FOR INITIATION OF CELL AND GENE THERAPY FIELD
9.1.4 INCREASED IMPLEMENTATION OF ADENO-ASSOCIATED VIRUS
9.1.5 TECHNOLOGICAL ADVANCEMENTS IN THE THAWING SYSTEMS
9.2 RESTRAINTS
9.2.1 RISE IN COST ASSOCIATED WITH CELL AND GENE THERAPY ENGINEERING
9.2.2 RISE OF UNWANTED MUTAGENS
9.2.3 TECHNICAL HINDRANCE FACED IN USING THAWING INSTRUMENTS
9.2.4 STRICT REGULATORY FRAMEWORK
9.3 OPPORTUNITIES
9.3.1 INCREASING PREVALENCE OF CANCER
9.3.2 STRATEGIC INITIATIVES BY MARKET PLAYERS
9.3.3 RISE IN EXPENDITURE IN HEALTHCARE SECTOR
9.4 CHALLENGES
9.4.1 LONG APPROVAL TIME FOR IMMUNOTHERAPIES
9.4.2 LACK OF ACCESSIBILITY
10 IMPACT OF COVID-19 ON MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET
10.1 IMPACT ON PRICE
10.2 IMPACT ON DEMAND
10.3 IMPACT ON SUPPLY CHAIN
10.4 STRATEGIC DECISION FOR MANUFACTURERS
10.5 CONCLUSION
11 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY
11.1 OVERVIEW
11.2 BENCH TOP
11.3 PORTABLE
12 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE
12.1 OVERVIEW
12.2 CELL THERAPIES
12.2.1 CAR T CELLS
12.2.2 NK CELLS
12.2.3 MSCS
12.2.4 TILS
12.2.5 OTHERS
12.3 GENE THERAPIES
12.3.1 ADENOVIRUS
12.3.2 ADENO-ASSOCIATED VIRUSES
12.3.3 LENTIVIRUSES
12.3.4 ONCOLYTIC VIRUSES
12.3.5 OTHERS
13 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE
13.1 OVERVIEW
13.2 AUTOMATIC THAWING SYSTEM
13.3 MANUAL THAWING SYSTEM
14 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION
14.1 OVERVIEW
14.2 UPSTREAM PROCESSING
14.2.1 AUTOMATIC THAWING SYSTEM
14.2.2 MANUAL THAWING SYSTEM
14.3 DOWNSTREAM PROCESSING
14.3.1 AUTOMATIC THAWING SYSTEM
14.3.2 MANUAL THAWING SYSTEM
15 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER
15.1 OVERVIEW
15.2 HOSPITALS AND DIAGNOSTIC LABORATORIES
15.3 BLOOD BANKS AND TRANSFUSION CENTERS
15.4 RESEARCH LABORATORIES AND ACADEMIC INSTITUTES
15.5 BIOTECHNOLOGY AND PHARMACEUTICAL INDUSTRY
15.6 CORD BLOOD AND STEM CELL BANKS
15.7 GENE BANKS
15.8 OTHERS
16 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL
16.1 OVERVIEW
16.2 DIRECT TENDER
16.3 THIRD PARTY DISTRIBUTORS
16.4 OTHERS
17 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION
17.1 MIDDLE EAST AND AFRICA
17.1.1 SOUTH AFRICA
17.1.2 SAUDI ARABIA
17.1.3 U.A.E.
17.1.4 EGYPT
17.1.5 ISRAEL
17.1.6 REST OF MIDDLE EAST AFRICA
18 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, COMPANY LANDSCAPE
18.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA
19 SWOT ANALYSIS
20 COMPANY PROFILE
20.1 MERCK KGAA
20.1.1 COMPANY SNAPSHOT
20.1.2 REVENUE ANALYSIS
20.1.3 PRODUCT PORTFOLIO
20.1.4 RECENT DEVELOPMENTS
20.2 EPPENDORF AG
20.2.1 COMPANY SNAPSHOT
20.2.2 REVENUE ANALYSIS
20.2.3 PRODUCT PORTFOLIO
20.2.4 RECENT DEVELOPMENTS
20.3 SARTORIUS AG
20.3.1 COMPANY SNAPSHOT
20.3.2 REVENUE ANALYSIS
20.3.3 PRODUCT PORTFOLIO
20.3.4 RECENT DEVELOPMENT
20.4 CYTIVA (A SUBSIDIARY OF DANAHER CORPORATION)
20.4.1 COMPANY SNAPSHOT
20.4.2 REVENUE ANALYSIS
20.4.3 PRODUCT PORTFOLIO
20.4.4 .RECENT DEVELOPMENTS
20.5 BARKEY
20.5.1 COMPANY SNAPSHOT
20.5.2 PRODUCT PORTFOLIO
20.5.3 RECENT DEVELOPMENTS
20.6 BOEKEL SCIENTIFIC
20.6.1 COMPANY SNAPSHOT
20.6.2 PRODUCT PORTFOLIO
20.6.3 RECENT DEVELOPMENT
20.7 BIOLINE INDIA
20.7.1 COMPANY SNAPSHOT
20.7.2 PRODUCT PORTFOLIO
20.7.3 RECENT DEVELOPMENTS
20.8 COOK
20.8.1 COMPANY SNAPSHOT
20.8.2 PRODUCT PORTFOLIO
20.8.3 RECENT DEVELOPMENT
20.9 GENESIS BPS
20.9.1 COMPANY SNAPSHOT
20.9.2 PRODUCT PORTFOLIO
20.9.3 RECENT DEVELOPMENTS
20.1 HELMER SCIENTIFIC INC.
20.10.1 COMPANY SNAPSHOT
20.10.2 PRODUCT PORTFOLIO
20.10.3 RECENT DEVELOPMENTS
20.11 LABCOLD
20.11.1 COMPANY SNAPSHOT
20.11.2 PRODUCT PORTFOLIO
20.11.3 RECENT DEVELOPMENTS
20.12 PLEURISTEM THERAPEUTICS INC.
20.12.1 COMPANY SNAPSHOT
20.12.2 REVENUE ANALYSIS
20.12.3 PRODUCT PORTFOLIO
20.12.4 RECENT DEVELOPMENTS
20.13 SARSTEDT AG & CO. KG
20.13.1 COMPANY SNAPSHOT
20.13.2 PRODUCT PORTFOLIO
20.13.3 RECENT DEVELOPMENTS
21 QUESTIONNAIRE
22 RELATED REPORTS
Liste des tableaux
TABLE 1 TOTAL HEALTH SPENDING BY THE U.S. (2015-2016)
TABLE 2 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 3 MIDDLE EAST AND AFRICA BENCH TOP IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 4 MIDDLE EAST AND AFRICA PORTABLE IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 5 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 6 MIDDLE EAST AND AFRICA CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 7 MIDDLE EAST AND AFRICA CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 8 MIDDLE EAST AND AFRICA GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 9 MIDDLE EAST AND AFRICA GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 10 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 11 MIDDLE EAST AND AFRICA AUTOMATIC THAWING SYSTEM IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 12 MIDDLE EAST AND AFRICA MANUAL THAWING SYSTEM IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 13 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 14 MIDDLE EAST AND AFRICA UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 15 MIDDLE EAST AND AFRICA UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 16 MIDDLE EAST AND AFRICA DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 17 MIDDLE EAST AND AFRICA DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 18 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 19 MIDDLE EAST AND AFRICA HOSPITALS AND DIAGNOSTIC LABORATORIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 20 MIDDLE EAST AND AFRICA BLOOD BANKS AND TRANSFUSION CENTERS IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 21 MIDDLE EAST AND AFRICA RESEARCH LABORATORIES AND ACADEMIC INSTITUTES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 22 MIDDLE EAST AND AFRICA BIOTECHNOLOGY AND PHARMACEUTICAL INDUSTRY IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 23 MIDDLE EAST AND AFRICA CORD BLOOD AND STEM CELL BANKS IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 24 MIDDLE EAST AND AFRICA GENE BANKS IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 25 MIDDLE EAST AND AFRICA OTHERS IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 26 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 27 MIDDLE EAST AND AFRICA DIRECT TENDER IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 28 MIDDLE EAST AND AFRICA THIRD PARTY DISTRIBUTORS IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 29 MIDDLE EAST AND AFRICA OTHERS IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY REGION, 2019-2028 (USD MILLION)
TABLE 30 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY COUNTRY, 2019-2028 (USD MILLION)
TABLE 31 MIDDLE EAST & AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 32 MIDDLE EAST & AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 33 MIDDLE EAST & AFRICA CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 34 MIDDLE EAST & AFRICA GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 35 MIDDLE EAST & AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 36 MIDDLE EAST & AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 37 MIDDLE EAST & AFRICA UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 38 MIDDLE EAST & AFRICA DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 39 MIDDLE EAST & AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 40 MIDDLE EAST & AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 41 SOUTH AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 42 SOUTH AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 43 SOUTH AFRICA CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 44 SOUTH AFRICA GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 45 SOUTH AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 46 SOUTH AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 47 SOUTH AFRICA UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 48 SOUTH AFRICA DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 49 SOUTH AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 50 SOUTH AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 51 SAUDI ARABIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 52 SAUDI ARABIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 53 SAUDI ARABIA CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 54 SAUDI ARABIA GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 55 SAUDI ARABIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 56 SAUDI ARABIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 57 SAUDI ARABIA UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 58 SAUDI ARABIA DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 59 SAUDI ARABIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 60 SAUDI ARABIA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 61 U.A.E. CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 62 U.A.E. CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 63 U.A.E. CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 64 U.A.E. GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 65 U.A.E. CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 66 U.A.E. CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 67 U.A.E. UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 68 U.A.E. DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 69 U.A.E. CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 70 U.A.E. CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 71 EGYPT CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 72 EGYPT CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 73 EGYPT CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 74 EGYPT GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 75 EGYPT CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 76 EGYPT CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 77 EGYPT UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 78 EGYPT DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 79 EGYPT CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 80 EGYPT CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 81 ISRAEL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
TABLE 82 ISRAEL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 83 ISRAEL CELL THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 84 ISRAEL GENE THERAPIES IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY SAMPLE, 2019-2028 (USD MILLION)
TABLE 85 ISRAEL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 86 ISRAEL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY APPLICATION, 2019-2028 (USD MILLION)
TABLE 87 ISRAEL UPSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 88 ISRAEL DOWNSTREAM PROCESSING IN CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY TYPE, 2019-2028 (USD MILLION)
TABLE 89 ISRAEL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY END USER, 2019-2028 (USD MILLION)
TABLE 90 ISRAEL CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)
TABLE 91 REST OF MIDDLE EAST AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET, BY MODALITY, 2019-2028 (USD MILLION)
Liste des figures
FIGURE 1 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: MIDDLE EAST AND AFRICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: MULTIVARIATE MODELLING
FIGURE 7 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 8 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: DBMR MARKET POSITION GRID
FIGURE 9 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 11 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: SEGMENTATION
FIGURE 12 NORTH AMERICA IS EXPECTED TO DOMINATE THE MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 13 INCREASE IN CASES OF GENETIC DISEASES SUCH AS CARDIAC AILMENTS, CYSTIC FIBROSIS AND AIDS IS EXPECTED TO DRIVE THE MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET IN THE FORECAST PERIOD OF 2021 TO 2028
FIGURE 14 TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET IN 2021 & 2028
FIGURE 15 PESTEL ANALYSIS
FIGURE 16 PORTERS FIVE FORCES MODEL
FIGURE 17 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET
FIGURE 18 INCIDENCE OF CYSTIC FIBROSIS OBSERVED IN THE COUNTRIES
FIGURE 19 PREVALENCE OF SICKLE CELL ANEMIA IN AFRICA AND EUROPE
FIGURE 20 NEW CANCER CASES WORLDWIDE, (2018) (IN MILLION)
FIGURE 21 MIDDLE EAST AND AFRICA CANCER INCIDENCE (2018)
FIGURE 22 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY MODALITY, 2020
FIGURE 23 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY MODALITY, 2021-2028 (USD MILLION)
FIGURE 24 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY MODALITY, CAGR (2021-2028)
FIGURE 25 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY MODALITY, LIFELINE CURVE
FIGURE 26 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET : BY SAMPLE, 2020
FIGURE 27 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET : BY SAMPLE, 2021-2028 (USD MILLION)
FIGURE 28 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET : BY SAMPLE, CAGR (2021-2028)
FIGURE 29 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY SAMPLE, LIFELINE CURVE
FIGURE 30 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET : BY TYPE, 2020
FIGURE 31 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET : BY TYPE, 2021-2028 (USD MILLION)
FIGURE 32 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET : BY TYPE, CAGR (2021-2028)
FIGURE 33 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY TYPE, LIFELINE CURVE
FIGURE 34 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY APPLICATION, 2020
FIGURE 35 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY APPLICATION, 2021-2028 (USD MILLION)
FIGURE 36 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY APPLICATION, CAGR (2021-2028)
FIGURE 37 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 38 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY END USER, 2020
FIGURE 39 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY END USER, 2021-2028 (USD MILLION)
FIGURE 40 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY END USER, CAGR (2021-2028)
FIGURE 41 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY END USER, LIFELINE CURVE
FIGURE 42 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, 2020
FIGURE 43 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, 2021-2028 (USD MILLION)
FIGURE 44 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)
FIGURE 45 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 46 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: SNAPSHOT (2020)
FIGURE 47 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY COUNTRY (2020)
FIGURE 48 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY COUNTRY (2021 & 2028)
FIGURE 49 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY COUNTRY (2020 & 2028)
FIGURE 50 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENT MARKET: BY MODALITY (2021-2028)
FIGURE 51 MIDDLE EAST AND AFRICA CELL AND GENE THERAPY THAWING EQUIPMENTMARKET: COMPANY SHARE 2020 (%)
FIGURE 52 COMPANY SHARE ANALYSIS
FIGURE 53 COMPANY SHARE ANALYSIS
FIGURE 54 COMPANY SHARE ANALYSIS
FIGURE 55 COMPANY SHARE ANALYSIS
Méthodologie de recherche
La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.
La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.
Personnalisation disponible
Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.
